35 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA
Market cap: $5.4K (12/21/2025)
Other Events
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Board, Management or Compensation, Other Events
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News, Material Contracts
Material disclosure
Announces Topline Data from SELECT-MDS-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome with RARA Gene Overexpression
Phase 2 Trial of Tamibarotene, Venetoclax, and Azacitidine in Untreated AML
Provides Update on SELECT-AML-1 Phase 2 Clinical Trial
Q3
Q2
Q1
FY 2023
FY 2022
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
S-8 POS